| The devil we know: is the use of injectable agents for the treatment of MDR-TB justified? A Reuter, P Tisile, D Von Delft, H Cox, V Cox, L Ditiu, A Garcia-Prats, ... The International Journal of Tuberculosis and Lung Disease 21 (11), 1114-1126, 2017 | 95 | 2017 |
| Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives E Lessem, H Cox, C Daniels, J Furin, L McKenna, CD Mitnick, T Mosidi, ... International Journal of Infectious Diseases 32, 56-60, 2015 | 48 | 2015 |
| Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise AK Coussens, SMA Zaidi, BW Allwood, PK Dewan, G Gray, M Kohli, ... The Lancet Respiratory Medicine 12 (6), 484-498, 2024 | 33 | 2024 |
| Analysing interventions designed to reduce tuberculosis-related stigma: A scoping review I Foster, M Galloway, W Human, M Anthony, H Myburgh, N Vanqa, ... PLOS Global Public Health 2 (10), e0000989, 2022 | 23 | 2022 |
| Measuring TB-related stigma A Maleche, B Citro, P Tisile, T Abdullaev The International Journal of Tuberculosis and Lung Disease 21 (11), S4-S5, 2017 | 14 | 2017 |
| The role of counselling in tuberculosis diagnostic evaluation and contact tracing: scoping review and stakeholder consultation of knowledge and research gaps I Foster, A Sullivan, G Makanda, I Schoeman, P Tisile, ... BMC Public Health 22 (1), 190, 2022 | 12 | 2022 |
| Target regimen profiles for tuberculosis treatment C Lienhardt, KE Dooley, P Nahid, C Wells, TS Ryckman, EA Kendall, ... Bulletin of the World Health Organization 102 (8), 600, 2024 | 5 | 2024 |
| Analysing interventions designed to reduce tuberculosis-related stigma: A scoping review. PLOS Global Public Health. 2022; 2 (10): e0000989 I Foster, M Galloway, W Human, M Anthony, H Myburgh, N Vanqa, ... Epub 2023/03/25.36962638 10.1371/journal. pgph. 0000989PMC10022226, 0 | 4 | |
| International consensus classification of early tuberculosis states to guide research for improved care and prevention: A Delphi exercise AK Coussens, SMA Zaidi, BA Allwood, PK Dewan, G Gray, M Kohli, ... The Lancet. Respiratory medicine 12 (6), 484, 2024 | 3 | 2024 |
| “This is an illness. No one is supposed to be treated badly”: community-based stigma assessments in South Africa to inform tuberculosis stigma intervention design I Foster, A Biewer, N Vanqa, G Makanda, P Tisile, SE Hayward, ... BMC Global and Public Health 2 (1), 41, 2024 | 2 | 2024 |
| Strengthening accountability for tuberculosis policy implementation in South Africa: perspectives from policymakers, civil society, and communities HM van der Westhuizen, J Giddy, R Coetzee, G Makanda, P Tisile, ... BMC Global and Public Health 2 (1), 48, 2024 | 1 | 2024 |
| “This is an illness. No one is supposed to be treated badly”: Community-based stigma assessments in South Africa to inform TB stigma intervention design I Foster, A Biewer, N Vanqa, G Makanda, P Tisile, SE Hayward, ... Research Square, 2023 | 1 | 2023 |
| Bedaquiline: what might the future hold? ES Shaw, NG Stoker, JL Potter, H Claassen, A Leslie, CD Tweed, ... The Lancet Microbe 5 (12), 2024 | | 2024 |
| Strengthening accountability for TB policy implementation in South Africa: perspectives from policymakers, civil society and communities HM Westhuizen, J Giddy, R Coetzee, G Makanda, P Tisile, M Galloway, ... | | 2024 |
| “As a patient I do not belong to the clinic, I belong to the community.” Co-developing a multi-level, person-centred tuberculosis stigma intervention in Cape Town, South Africa SE Hayward, N Vanqa, G Makanda, P Tisile, L Ngwatyu, I Foster, ... Research Square, 2024 | | 2024 |
